ivf
(10)
Onto Health Bet $28 Million That Fertility Care Should Start Before the Panic
Most fertility businesses sell a treatment after something goes wrong. Onto Health is trying to sell clarity earlier - then use clinics, software and a $20 million Series A to carry patients through what comes next.
The Rice-Sized Sensor Trying to End the IVF Blood-Test Marathon
A fertility patient can give blood every other day for weeks and still miss the hormone surges that decide whether a cycle works. Impli wants to put a continuous read of that biology under the skin - or on it.
The Company That Made IVF an Employee Benefit
How a fertility website became a Nasdaq-listed benefits company covering millions of employees - and why big employers hand it the hardest part of their health plan.
Carrot Fertility
Carrot Fertility is a global fertility and family-building benefits platform that employers and health plans offer to their people. It covers the full journey - fertility preservation, IVF and IUI, pregnancy, adoption, surrogacy, low-testosterone care and menopause - with an expert Care Team, a global provider network, and the Carrot Card payment platform. Founded in 2016 after co-founder Tammy Sun faced a five-figure out-of-pocket egg-freezing bill, Carrot serves members in more than 195 countries and positions itself as a data-driven, outcomes-focused alternative to leaving fertility care to employees to navigate alone.
Univfy
Univfy is a California-based health-AI company that uses machine learning to give IVF patients personalized, center-specific predictions of their probability of a live birth. Founded by Stanford researchers Dr. Mylene Yao and Prof. Wing H. Wong, its platform analyzes thousands of real IVF cycles to move beyond age-only estimates, powering patient counseling, fertility benefits for employers and health plans, and IVF refund/warranty programs that make treatment more affordable and predictable.
Dandi Fertility
Dandi Fertility is a New York-based femtech company that makes the physical and emotional grind of IVF a little less lonely. Its patent-pending IVF Care Kit - a heating pad, cooling pad, shot targets, a hands-free supply belt and a massage ball - is paired with a virtual care platform staffed by registered fertility nurses licensed across all 50 states. Founded in 2021 by fertility nurse Leyla Bilali and CEO Jake Kent, Dandi sells directly to patients and to fertility clinics, and its Care Kit was named one of TIME's 200 Best Inventions of 2024.
Granata Bio
Granata Bio is a Boston-based biopharmaceutical company building a portfolio of fertility and reproductive-health therapies. Founded in 2018, it in-licenses and develops medications used in IVF outside the US, runs its own clinical programs, and is expanding into ovarian biology. Its lead asset is an investigational human menopausal gonadotropin in the pivotal Phase III GRACE study, and its 2025 acquisition of Oviva Therapeutics added a first-in-class therapeutic aimed at extending ovarian function. The company targets the multi-billion-dollar global infertility medication market with the goal of expanding patient access and improving IVF outcomes.
Nucleus Genomics
Nucleus Genomics is a New York-based consumer genomics company that sells a $399 at-home, clinical-grade whole-genome sequencing kit and a software platform that turns a person's full DNA sequence into readable reports on disease risk, carrier status, traits, and longevity. Founded in 2021 by Thiel Fellow Kian Sadeghi, Nucleus pairs whole-genome data with polygenic risk scores and lifestyle inputs to estimate risk for common, complex conditions. In 2025 it expanded into reproductive products - carrier screening, partner DNA alignment, and a controversial embryo-ranking tool, Nucleus Embryo - that put the company at the center of a public debate over the science and ethics of genetic selection.
Alife Health
Alife Health is a San Francisco-based health technology company building AI-powered software for IVF clinics. Its platform helps embryologists grade embryos, helps reproductive endocrinologists time ovarian stimulation, and helps clinics streamline scheduling and patient communication - all aimed at improving outcomes and lowering the cost of fertility care.
Orchid
Orchid is a reproductive genetics company offering the first commercially available whole-genome sequencing test for IVF embryos. Founded by Noor Siddiqui in 2019, Orchid reads more than 99% of an embryo's genome before implantation and screens for over 1,200 monogenic conditions, chromosomal abnormalities, de novo mutations, and polygenic disease risk - so prospective parents can make informed choices before pregnancy begins.